Depiction of Episode two: The contribution of good corporate governance to the market valuation of European companies

Episode two: The contribution of good corporate governance to the market valuation of European companies



Brussels was the ideal setting for our most recent two-part Agenda podcast, where the European Contact Group brought together different stakeholders to discuss the results of Oxera’s report, An analysis of the EU governance framework for corporate reporting.

In episode two of the podcast, the discussion addresses how, in practice, policies could be formed to promote an effort that encourages good corporate reporting.

Russell Goldsmith is joined by Pablo Zalba, Partner and EU Policy Managing Director at Deloitte, who chaired the panel including Rients Abma, Executive Director, Eumedion, Daniel Blume, Senior Policy Analyst at OECD, Isabelle Grauer-Gaynor, Head of Corporate Finance and Report Uniot at the European Securities and Markets Authority and finally Roberto Cravero, NED Community and Senior Managing Partner, Cravero&Associates.

Related

Articles
7 minute read
Depiction of Adding value with a portfolio approach to funding reduction

Adding value with a portfolio approach to funding reduction

Budgets for capital projects are coming under pressure as funding is not being maintained in real price terms. The response from portfolio managers has been to cancel or postpone future projects or slow the pace of ongoing projects. If this is undertaken on an individual project level, it could lead… Read More

Articles
5 minute read
Depiction of Consumer Duty board reports: are firms prepared for the July 2024 deadline?

Consumer Duty board reports: are firms prepared for the July 2024 deadline?

The UK Financial Conduct Authority’s (FCA) Consumer Duty, a new outcomes-based regulation for financial services firms, has now been in force for over six months. July 2024 will see the deadline for the first annual Consumer Duty board reports. We share our reflections on the importance of these documents and… Read More

Back to top